Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Keymed Biosciences Co.Ltd clinical trials
The registry lists 69 studies whose lead sponsor is Keymed Biosciences Co.Ltd or one of 1 company grouped under it. 34 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.
Keep track of what changes. Save the Keymed Biosciences Co.Ltd studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesWhere
- China
- 65
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Keymed Biosciences Co.Ltd.
- Keymed Biosciences Co.Ltd66 studiesSame company
Something wrong?
- Beijing Keymed Biosciences Co., Ltd.3 studies →Subsidiary
Something wrong?
Focus areas
Conditions Keymed Biosciences Co.Ltd leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 69. Browse all 69 →
- Study of CM529D1 in Participants With Advanced Solid TumorsNot yet recruitingNCT07893171Phase 1/2
- Study of CM512 Injection in Patients With Perennial Allergic Rhinitis on Background TherapyNot yet recruitingNCT07890350Phase 2
Sponsor listed in the registry: Beijing Keymed Biosciences Co., Ltd.
- Study of CM583 in Healthy ParticipantsNot yet recruitingNCT07823764Phase 1
- A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis (NEZHA-3)Not yet recruitingNCT07807826Phase 3
Sponsor listed in the registry: Beijing Keymed Biosciences Co., Ltd.
- A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis (NEZHA-2)Not yet recruitingNCT07519577Phase 2
- Study of CM518D1 in Patients With Advanced Solid TumorsRecruitingNCT07019779Phase 1/2
- CM336 for Active Sjogren's Syndrome StudyNot yet recruitingNCT07642843Phase 1
- Study of CM512 Injection in Subjects With Chronic Spontaneous Urticaria(CSU)RecruitingNCT07166211Phase 2
- Study of CM383 in Healthy SubjectsRecruitingNCT07292688Phase 1
- A Study of CM336 in Patients With Relapsed or Refractory Autoimmune CytopeniaRecruitingNCT07175493Phase 1/2
- Study Evaluating the Efficacy and Safety of CM336 Injection in the Treatment of Light-Chain AmyloidosisRecruitingNCT07039578Phase 2
- A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.RecruitingNCT07230483Phase 2
- Study of CM559 in Healthy SubjectsRecruitingNCT07175506Phase 1
- Study of CM313 in Subject With IgA NephropathyNot yet recruitingNCT06830395Phase 2
- Study of CM336 in Relapsed or Refractory Multiple Myeloma PatientsNot yet recruitingNCT07181239Phase 3
- Study of CM512 Injection in Subjects With Moderate-to-severe AsthmaRecruitingNCT07011524Phase 2
- Study of CM512 in Patients With Moderate-to-Severe Atopic DermatitisRecruitingNCT06947980Phase 2
- Study of CM313(SC) Injection in Subjects With Platelet Transfusion RefractorinessRecruitingNCT06792019Phase 1/2
- A Study of Stapokibatrt in Children Subjects With Atopic DermatitisNot yet recruitingNCT07106372Phase 3
- A Study of CM512 in Subjects With Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseNot yet recruitingNCT06980142Phase 2
- A Study of CM350 in Patients With Advanced Solid TumorsRecruitingNCT05263960Phase 1/2
- Study of Stapokibatrt in Children Subjects With Atopic DermatitisNot yet recruitingNCT06956196Phase 3
- A Study of CM383 in Patients With Alzheimer's Disease Related Mild Cognitive Impairment and Mild Alzheimer's DiseaseRecruitingNCT06619613Phase 1
- Study of CM313(SC) Injection in Subjects With Relapsed/Refractory Aplastic AnemiaNot yet recruitingNCT06791824Phase 1/2
- Study of CM313(SC) Injection in Systemic Lupus Erythematosus(SLE)Not yet recruitingNCT06791772Phase 2
- Single Dose Escalation Study of CM383 in Healthy VolunteersRecruitingNCT06412185Phase 1
- Study of Stapokibart Injection in Patients With Allergic RhinitisRecruitingNCT06525597Phase 2
- Study of CM313 in Healthy SubjectsRecruitingNCT06285227Phase 1
- A Study of CM336 in Patients With Relapsed or Refractory Multiple MyelomaRecruitingNCT05299424Phase 1/2
- Clinical Study of CM338 in the Treatment of Immunoglobulin A NephropathyRecruitingNCT05775042Phase 2
- Study of CM326 in Participants With Chronic Rhinosinusitis With Nasal PolyposisNot yet recruitingNCT06372678Phase 2
- Study of CM310 in Subjects With Seasonal Allergic RhinitisNot yet recruitingNCT06171074Phase 2
- Study Evaluating the Pharmacokinetics of CM310 in Healthy SubjectsNot yet recruitingNCT06171048Phase 1
- A Study of CM313 in Subjects With Relapsed or Refractory Multiple MyelomaNot yet recruitingNCT06126237Phase 1/2
- A Study of CM310 in Subjects With Moderate-to-Severe Atopic DermatitisCompletedNCT06116565Phase 2
- A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis (NEZHA-1)CompletedNCT06930612Phase 2
Sponsor listed in the registry: Beijing Keymed Biosciences Co., Ltd.
- Study on the Treatment of Prurigo Nodularis With Stapokibart InjectionCompletedNCT06424470Phase 3
- Study of CM310 Injection in Adolescent Subjects With Atopic DermatisCompletedNCT06277765Phase 3
- Study of CM310 in Adolescent Subjects With Atopic DermatisActive, not recruitingNCT06495229Phase 3
- Study of CM512 in Healthy Subjects and Patients With Atopic DermatitisCompletedNCT06553209Phase 1
- Study of CM313 (SC) Injection in Subjects With Primary Immune Thrombocytopenia (ITP)Active, not recruitingNCT06594146Phase 2
- Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901CompletedNCT04805307Phase 1
- A Study of CM310 in Children Patients With Moderate-to-severe Atopic DermatisCompletedNCT05579925Phase 2
- A Study of CM310 in Patients With Moderate-to-Severe Atopic DermatitisCompletedNCT05265923Phase 3
- Study of CM310 in Subjects With Allergic RhinitisCompletedNCT05908032Phase 3
- The Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal PolypsCompletedNCT05131464Phase 2
- Study of CM310 in Patients With Allergic RhinitisCompletedNCT05908721Phase 2
- A Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyposis (CROWNS-2)CompletedNCT05436275Phase 3
- A Study of CM326 in Patients With Chronic Rhinosinusitis With Nasal PolypsCompletedNCT05324137Phase 1/2
- Single Ascending Dose Study of CM338 in Healthy VolunteersCompletedNCT05186285Phase 1